ANTAGONISTIC SELECTIVE BINDING AGENTS OF OSTEOPROTEGERIN BINDING PROTEIN

摘要

Selective binding agents of osteoprotegerin binding protein (OPGbp) are provided by the invention. More particularly, the invention provides for antibodies and antigen binding domains which selectively bind to OPGbp and m ay be used to prevent or treat conditions relating to loss of bone mass. Nuclei c acid molecules encoding said antibodies and antigen binding domains, and expression vectors and host cells for the production of same are also provid ed.